Tamoxifen shown to reduce gynecomastia in PCa patients

Tamoxifen (Nolvadex) reduces the frequency of gynecomastia and breast pain in prostate cancer patients taking bicalutamide (Casodex), according to a study in Lancet Oncology (2005; 6:295-300).

Related Content:

Female UrologyCosmetic Surgery

FPMRS patients evaluate televisits through survey-based study

Evaluating the feasibility of telemedicine in a post-pandemic world

Investigators assess the satisfaction of telehealth visits in FPMRS patients